Clinical Trial: A Phase 1 Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of TL-001 in Healthy Adult Participants

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06867796) titled 'A Phase 1 Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of TL-001 in Healthy Adult Participants' on March 04.

Brief Summary: The goal of this study is to evaluate safety, tolerability, pharmacokinetics (PK)), pharmacodynamics (PD) and immunogenicity of single and multiple ascending dose of TL-001 in healthy adult participants.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: TL-001

Intravenously administered

DRUG: Placebo

Intravenously administered

Recruitment Status: NOT_YET_RECRUITING

Sponsor: TrueLab Biopharmaceutical Co.,...